GEN Exclusives

More »

GEN News Highlights

Back to Item »

Plexxikon and Roche Report Positive Data from Phase III BRAF Mutation Melanoma Study

Trial found Vemurafenib to be more effective than chemotherapy in terms of tumor shrinkage and survival.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Children and Antipsychotic Drugs

Do you think children and adolescents with behavioral problems are overmedicated?